首页|基于网络药理学探讨补体抗痨散治疗肺结核的作用机制

基于网络药理学探讨补体抗痨散治疗肺结核的作用机制

扫码查看
目的:基于网络药理学探讨补体抗痨散对肺结核的作用机制.方法:通过中药系统药理数据库和分析平台(TCM-SP)收集补体抗痨散的主要化学成分,根据药物分布、吸收、代谢、排泄(ADME)筛选出口服利用度筛选药物活性成分,并获取对应靶点;通过Drugbank、Genecards、OMIM数据库获得肺结核(pulmonary tuberculosis PTB)的重要靶点并去除重复值,利用String数据库进行蛋白质相互作用分析,构建PPI网络;使用Cytoscape3.7.1构建"补体抗痨散-肺结核靶点-通路"网络.并利用Cytoscape3.7.1软件筛选出排名靠前的核心靶点;使用微生信数据库对PPI中的靶点进行基因本体(GO)功能及京都基因和基因组(KEGG)信号通路富集分析.结果:筛选出补体抗痨散232个药物靶点,肺结核1452个非重复疾病靶点,两者取交集,共获得110个共同交集靶点.Cytoscape3.7.1筛选出排名前五的核心靶点:槲皮素、山奈酚、木犀草素、异鼠李素、常春藤皂苷元,PPI分析得到的RELA、TP53、TNF、AKT1、IL-6为核心的基因靶点.结论:补体抗痨散通过多靶点、多途径发挥其治疗肺结核的作用.
Action mechanism of tonic anti-TB granules in the treatment of pulmonary tu-berculosis based on network pharmacology
This paper explores the action mechanism of tonic anti-TB granules in the treatment of pulmonary tu-berculosis based on network pharmacology.The main chemical components of tonic anti-TB granules are collected in TCMSP database,the active ingredients are screened out based on drug distribution,absorption,metabolism and excretion(ADME),and the corresponding targets are obtained.The important targets of pulmonary tuberculosis(PTB)are obtained in Drugbank,Genecards and OMIM databases,and the duplicate values are removed.Protein interaction analysis is performed using String database,and the PPI network is constructed.The drug-disease targets-pathway network is constructed by using Cytoscape 3.7.1,and the top-ranked core targets are screened out.GO function and KEGG signaling pathway enrichment analysis are performed on the targets in the PPI network by using Microbiology database.232 drug targets and 1452 non-duplicated disease targets are screened out,and 110 intersec-ted targets are obtained.The top five core targets are quercetin,kaempferol,luteolin,isorhamnetin,and hederagenin.PPI analysis show that RELA,TP53,TNF,AKT1 and IL-6 are the core gene targets.In conclusion,tonic anti-TB granules exert the therapeutic effect on pulmonary tuberculosis through multi-targets and multi-pathways.

tonic anti-TB granulesnetwork pharmacologytuberculosis

汪鸣霄、李若尘、周洵

展开 >

贵州中医药大学,贵州 贵阳 550025

朱祝生全国名老中医药专家传承工作室,贵州 贵阳 550025

贵州中医药大学第二附属医院,贵州 贵阳 550003

补体抗痨散 网络药理学 肺结核

国家中医药管理局全国名老中医专家传承工作室建设项目朱祝生全国名老中医药专家传承工作室

国中医药办人教函[2022]75号

2024

贵州科学
贵州科学院

贵州科学

影响因子:0.395
ISSN:1003-6563
年,卷(期):2024.42(2)
  • 19